Severe fever with thrombocytopenia virus glycoproteins are targeted by neutralizing antibodies and can use DC-SIGN as a receptor for pH-dependent entry into human and animal cell lines

Journal of Virology

Volumn 87, Issue 8, 2013, Pages 4384-4394

  Hofmann, Heike ^a   Li, Xingxing ^b   Zhang, Xiaoai ^c   Liu, Wei ^c   Kühl, Annika ^a   Kaup, Franziska ^a   Soldan, Samantha S ^d   González Scarano, Francisco ^e   Weber, Friedemann ^f   He, Yuxian ^b   Pöhlmann, Stefan ^a  

^a GERMAN PRIMATE CENTER   (Germany)

^b INSTITUTE OF PATHOGEN BIOLOGY   (China)

^c BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e University of Texas Health Science Center   (United States)

^f PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; CATHEPSIN L; CD209 ANTIGEN; GLYCOPROTEIN GC; GLYCOPROTEIN GN; LENTIVIRUS VECTOR; NEUTRALIZING ANTIBODY; RHABDOVIRUS VECTOR; SERINE PROTEINASE; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS VECTOR;

ANIMAL CELL; ANTIBODY DETECTION; ARTICLE; BUNYAVIRUS; CONTROLLED STUDY; DENDRITIC CELL; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; LA CROSSE VIRUS; MACROPHAGE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PH; PRIORITY JOURNAL; PROTEIN TARGETING; RIFT VALLEY FEVER BUNYAVIRUS; SEVERE FEVER WITH THROMBOCYTOPENIA VIRUS; TROPISM; VIRUS CELL INTERACTION; VIRUS ENTRY;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CELL ADHESION MOLECULES; CELL LINE; DENDRITIC CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; LECTINS, C-TYPE; MACROPHAGES; MEMBRANE GLYCOPROTEINS; ORTHOBUNYAVIRUS; RECEPTORS, CELL SURFACE; RECEPTORS, VIRUS; SERINE PROTEASES; VIRAL ENVELOPE PROTEINS; VIRAL TROPISM; VIRUS INTERNALIZATION;

ANIMALIA; LA CROSSE VIRUS; ORTHOBUNYAVIRUS; RIFT VALLEY FEVER VIRUS;

EID: 84875771499     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02628-12     Document Type: Article

References (65)

1. Walter CT, Barr JN. 2011. Recent advances in the molecular and cellular biology of bunyaviruses. J. Gen. Virol. 92:2467-2484.
2. Jonsson CB, Figueiredo LT, Vapalahti O. 2010. A global perspective on hantavirus ecology, epidemiology, and disease. Clin. Microbiol. Rev. 23: 412-441.
3. Boshra H, Lorenzo G, Busquets N, Brun A. 2011. Rift Valley fever: recent insights into pathogenesis and prevention. J. Virol. 85:6098-6105.
4. Hollidge BS, Gonzalez-Scarano F, Soldan SS. 2010. Arboviral encephalitides: transmission, emergence, and pathogenesis. J. Neuroimmune Pharmacol. 5:428-442.
5. Ikegami T, Makino S. 2009. Rift valley fever vaccines. Vaccine 27(Suppl. 4):D69-D72.
6. Yu XJ, Liang MF, Zhang SY, Liu Y, Li JD, Sun YL, Zhang L, Zhang QF, Popov VL, Li C, Qu J, Li Q, Zhang YP, Hai R, Wu W, Wang Q, Zhan FX, Wang XJ, Kan B, Wang SW, Wan KL, Jing HQ, Lu JX, Yin WW, Zhou H, Guan XH, Liu JF, Bi ZQ, Liu GH, Ren J, Wang H, Zhao Z, Song JD, He JR, Wan T, Zhang JS, Fu XP, Sun LN, Dong XP, Feng ZJ, Yang WZ, Hong T, Zhang Y, Walker DH, Wang Y, Li DX. 2011. Fever with thrombocytopenia associated with a novel bunyavirus in China. N. Engl. J. Med. 364:1523-1532.
7. Bao CJ, Guo XL, Qi X, Hu JL, Zhou MH, Varma JK, Cui LB, Yang HT, Jiao YJ, Klena JD, Li LX, Tao WY, Li X, Chen Y, Zhu Z, Xu K, Shen AH, Wu T, Peng HY, Li ZF, Shan J, Shi ZY, Wang H. 2011. A family cluster of infections by a newly recognized bunyavirus in eastern China, 2007: further evidence of person-to-person transmission. Clin. Infect. Dis. 53: 1208-1214.
8. Liu Y, Li Q, Hu W, Wu J, Wang Y, Mei L, Walker DH, Ren J, Wang Y, Yu XJ. 2012. Person-to-person transmission of severe fever with thrombocytopenia syndrome virus. Vector Borne Zoonotic Dis. 12:156-160.
9. Gai Z, Liang M, Zhang Y, Zhang S, Jin C, Wang SW, Sun L, Zhou N, Zhang Q, Sun Y, Ding SJ, Li C, Gu W, Zhang F, Wang Y, Bian P, Li X, Wang Z, Song X, Wang X, Xu A, Bi Z, Chen S, Li D. 2012. Person-toperson transmission of severe fever with thrombocytopenia syndrome bunyavirus through blood contact. Clin. Infect. Dis. 54:249-252.
10. McMullan LK, Folk SM, Kelly AJ, MacNeil A, Goldsmith CS, Metcalfe MG, Batten BC, Albarino CG, Zaki SR, Rollin PE, Nicholson WL, Nichol ST. 2012. A new phlebovirus associated with severe febrile illness in Missouri. N. Engl. J. Med. 367:834-841.
11. Marklewitz M, Handrick S, Grasse W, Kurth A, Lukashev A, Drosten C, Ellerbrok H, Leendertz FH, Pauli G, Junglen S. 2011. Gouleako virus isolated from West African mosquitoes constitutes a proposed novel genus in the family Bunyaviridae. J. Virol. 85:9227-9234.
12. Schmaljohn CS, Nichol ST. 2007. Bunyaviridae, p 1741-1789. In Knipe DM, Howley PM, Fields virology, 5th ed. Lippincott Williams & Wilson, Philadelphia, PA.
13. Nakitare GW, Elliott RM. 1993. Expression of the Bunyamwera virus M genome segment and intracellular localization of NSm. Virology 195:511-520.
14. Salanueva IJ, Novoa RR, Cabezas P, Lopez-Iglesias C, Carrascosa JL, Elliott RM, Risco C. 2003. Polymorphism and structural maturation of bunyamwera virus in Golgi and post-Golgi compartments. J. Virol. 77: 1368-1381.
15. Lappin DF, Nakitare GW, Palfreyman JW, Elliott RM. 1994. Localization of Bunyamwera bunyavirus G1 glycoprotein to the Golgi requires association with G2 but not with NSm. J. Gen. Virol. 75:3441-3451.
16. Wasmoen TL, Kakach LT, Collett MS. 1988. Rift Valley fever virus M segment: cellular localization of M segment-encoded proteins. Virology 166:275-280.
17. Lozach PY, Mancini R, Bitto D, Meier R, Oestereich L, Overby AK, Pettersson RF, Helenius A. 2010. Entry of bunyaviruses into mammalian cells. Cell Host. Microbe 7:488-499.
18. Lozach PY, Kuhbacher A, Meier R, Mancini R, Bitto D, Bouloy M, Helenius A. 2011. DC-SIGN as a receptor for phleboviruses. Cell Host Microbe 10:75-88.
19. Gavrilovskaya IN, Shepley M, Shaw R, Ginsberg MH, Mackow ER. 1998. Beta3 integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc. Natl. Acad. Sci. U. S. A. 95:7074-7079.
20. Gavrilovskaya IN, Brown EJ, Ginsberg MH, Mackow ER. 1999. Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by beta3 integrins. J. Virol. 73:3951-3959.
21. Krautkramer E, Zeier M. 2008. Hantavirus causing hemorrhagic fever with renal syndrome enters from the apical surface and requires decayaccelerating factor (DAF/CD55). J. Virol. 82:4257-4264.
22. Wu L, Martin TD, Carrington M, KewalRamani VN. 2004. Raji B cells, misidentified as THP-1 cells, stimulate DC-SIGN-mediated HIV transmission. Virology 318:17-23.
23. Gramberg T, Hofmann H, Moller P, Lalor PF, Marzi A, Geier M, Krumbiegel M, Winkler T, Kirchhoff F, Adams DH, Becker S, Munch J, Pöhlmann S. 2005. LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus. Virology 340:224-236.
24. Habjan M, Penski N, Spiegel M, Weber F. 2008. T7 RNA polymerasedependent and -independent systems for cDNA-based rescue of Rift Valley fever virus. J. Gen. Virol. 89:2157-2166.
25. Plassmeyer ML, Soldan SS, Stachelek KM, Roth SM, Martin-Garcia J, Gonzalez-Scarano F. 2007. Mutagenesis of the La Crosse Virus glycoprotein supports a role for Gc (1066-1087) as the fusion peptide. Virology 358:273-282.
26. Simmons G, Reeves JD, Grogan CC, Vandenberghe LH, Baribaud F, Whitbeck JC, Burke E, Buchmeier MJ, Soilleux EJ, Riley JL, Doms RW, Bates P, Pöhlmann S. 2003. DC-SIGN and DC-SIGNR bind Ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology 305:115-123.
27. Gao F, Li Y, Decker JM, Peyerl FW, Bibollet-Ruche F, Rodenburg CM, Chen Y, Shaw DR, Allen S, Musonda R, Shaw GM, Zajac AJ, Letvin N, Hahn BH. 2003. Codon usage optimization of HIV type 1 subtype C gag, pol, env, and nef genes: in vitro expression and immune responses in DNA-vaccinated mice. AIDS Res. Hum. Retroviruses 19:817-823.
28. Jameson B, Baribaud F, Pöhlmann S, Ghavimi D, Mortari F, Doms RW, Iwasaki A. 2002. Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques. J. Virol. 76: 1866-1875.
29. Connor RI, Chen BK, Choe S, Landau NR. 1995. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206:935-944.
30. Chong H, Hong K, Zhang C, Nie J, Song A, Kong W, Wang Y. 2008. Genetic and neutralization properties of HIV-1 env clones from subtype B/BC/AE infections in China. J. Acquir. Immune Defic. Syndr. 47:535-543.
31. Kuhl A, Hoffmann M, Muller MA, Munster VJ, Gnirss K, Kiene M, Tsegaye TS, Behrens G, Herrler G, Feldmann H, Drosten C, Pöhlmann S. 2011. Comparative analysis of Ebola virus glycoprotein interactions with human and bat cells. J. Infect. Dis. 204(Suppl. 3):S840 -S849.
32. Berger Rentsch M, Zimmer G. 2011. A vesicular stomatitis virus replicon- based bioassay for the rapid and sensitive determination of multispecies type I interferon. PLoS One 6:e25858. doi:10.1371/journal.pone .0025858.
33. Hanika A, Larisch B, Steinmann E, Schwegmann-Wessels C, Herrler G, Zimmer G. 2005. Use of influenza C virus glycoprotein HEF for generation of vesicular stomatitis virus pseudotypes. J. Gen. Virol. 86:1455-1465.
34. Niwa H, Yamamura K, Miyazaki J. 1991. Efficient selection for highexpression transfectants with a novel eukaryotic vector. Gene 108:193-199.
35. Takada A, Robison C, Goto H, Sanchez A, Murti KG, Whitt MA, Kawaoka Y. 1997. A system for functional analysis of Ebola virus glycoprotein. Proc. Natl. Acad. Sci. U. S. A. 94:14764-14769.
36. O'Doherty U, Swiggard WJ, Malim MH. 2000. Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J. Virol. 74:10074-10080.
37. Superti F, Seganti L, Ruggeri FM, Tinari A, Donelli G, Orsi N. 1987. Entry pathway of vesicular stomatitis virus into different host cells. J. Gen. Virol. 68:387-399.
38. McClure MO, Marsh M, Weiss RA. 1988. Human immunodeficiency virus infection of CD4-bearing cells occurs by a pH-independent mechanism. EMBO J. 7:513-518.
39. McClure MO, Sommerfelt MA, Marsh M, Weiss RA. 1990. The pH independence of mammalian retrovirus infection. J. Gen. Virol. 71: 767-773.
40. Hofmann H, Hattermann K, Marzi A, Gramberg T, Geier M, Krumbiegel M, Kuate S, Uberla K, Niedrig M, Pöhlmann S. 2004. S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients. J. Virol. 78:6134-6142.
41. Wool-Lewis RJ, Bates P. 1998. Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. J. Virol. 72:3155-3160.
42. Chandran K, Sullivan NJ, Felbor U, Whelan SP, Cunningham JM. 2005. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308:1643-1645.
43. Simmons G, Gosalia DN, Rennekamp AJ, Reeves JD, Diamond SL, Bates P. 2005. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc. Natl. Acad. Sci. U. S. A. 102:11876-11881.
44. Gnirss K, Kuhl A, Karsten C, Glowacka I, Bertram S, Kaup F, Hofmann H, Pöhlmann S. 2012. Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of TMPRSS2 expression. Virology 424:3-10.
45. Schornberg K, Matsuyama S, Kabsch K, Delos S, Bouton A, White J. 2006. Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J. Virol. 80:4174-4178.
46. Hollidge BS, Nedelsky NB, Salzano MV, Fraser JW, Gonzalez-Scarano F, Soldan SS. 2012. Orthobunyavirus entry into neurons and other mammalian cells occurs via clathrin-mediated endocytosis and requires trafficking into early endosomes. J. Virol. 86:7988-8001.
47. Santos RI, Rodrigues AH, Silva ML, Mortara RA, Rossi MA, Jamur MC, Oliver C, Arruda E. 2008. Oropouche virus entry into HeLa cells involves clathrin and requires endosomal acidification. Virus Res. 138:139-143.
48. Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, Kirchhausen T. 2006. Dynasore, a cell-permeable inhibitor of dynamin. Dev. Cell 10:839-850.
49. Mulherkar N, Raaben M, de la Torre JC, Whelan SP, Chandran K. 2011. The Ebola virus glycoprotein mediates entry via a non-classical dynamindependent macropinocytic pathway. Virology 419:72-83.
50. Hunt CL, Kolokoltsov AA, Davey RA, Maury W. 2011. The Tyro3 receptor kinase Axl enhances macropinocytosis of Zaire Ebola virus. J. Virol. 85:334-347.
51. Araki N, Johnson MT, Swanson JA. 1996. A role for phosphoinositide 3-kinase in the completion of macropinocytosis and phagocytosis by macrophages. J. Cell Biol. 135:1249-1260.
52. Aleksandrowicz P, Marzi A, Biedenkopf N, Beimforde N, Becker S, Hoenen T, Feldmann H, Schnittler HJ. 2011. Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis. J. Infect. Dis. 204(Suppl. 3):S957-S967.
53. Tsegaye TS, Pöhlmann S. 2010. The multiple facets of HIV attachment to dendritic cell lectins. Cell Microbiol. 12:1553-1561.
54. Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J, Cornelissen IL, Nottet HS, KewalRamani VN, Littman DR, Figdor CG, van Kooyk Y. 2000. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100: 587-597.
55. Garigliany MM, Hoffmann B, Dive M, Sartelet A, Bayrou C, Cassart D, Beer M, Desmecht D. 2012. Schmallenberg virus in calf born at term with porencephaly, Belgium. Emerg. Infect. Dis. 18:1005-1006.
56. Muskens J, Smolenaars AJ, van der Poel WH, Mars MH, vanWuijckhuise L, Holzhauer M, van Weering H, Kock P. 2012. Diarrhea and loss of production on Dutch dairy farms caused by the Schmallenberg virus. Tijdschr. Diergeneeskd. 137:112-115.
57. van den Brom R, Luttikholt SJ, Lievaart-Peterson K, Peperkamp NH, Mars MH, van der Poel WH, Vellema P. 2012. Epizootic of ovine congenital malformations associated with Schmallenberg virus infection. Tijdschr. Diergeneeskd. 137:106-111.
58. Ducomble T, Wilking H, Stark K, Takla A, Askar M, Schaade L, Nitsche A, Kurth A. 2012. Lack of evidence for Schmallenberg virus infection in highly exposed persons, Germany, 2012. Emerg. Infect. Dis. 18:1333-1335.
59. Ogino M, Ebihara H, Lee BH, Araki K, Lundkvist A, Kawaoka Y, Yoshimatsu K, Arikawa J. 2003. Use of vesicular stomatitis virus pseudotypes bearing hantaan or Seoul virus envelope proteins in a rapid and safe neutralization test. Clin. Diagn. Lab. Immunol. 10:154-160.
60. Jin C, Liang M, Ning J, Gu W, Jiang H, Wu W, Zhang F, Li C, Zhang Q, Zhu H, Chen T, Han Y, Zhang W, Zhang S, Wang Q, Sun L, Liu Q, Li J, Wang T, Wei Q, Wang S, Deng Y, Qin C, Li D. 2012. Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57/ BL6 mouse model. Proc. Natl. Acad. Sci. U. S. A. 109:10053-10058.
61. Helenius A, Kartenbeck J, Simons K, Fries E. 1980. On the entry of Semliki forest virus into BHK-21 cells. J. Cell Biol. 84:404-420.
62. Mothes W, Boerger AL, Narayan S, Cunningham JM, Young JA. 2000. Retroviral entry mediated by receptor priming and lowpHtriggering of an envelope glycoprotein. Cell 103:679-689.
63. Volchkov VE, Feldmann H, Volchkova VA, Klenk HD. 1998. Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc. Natl. Acad. Sci. U. S. A. 95:5762-5767.
64. Marzi A, Reinheckel T, Feldmann H. 2012. Cathepsin B and L are not required for Ebola virus replication. PLoS Negl. Trop. Dis. 6:e1923. doi: 10.1371/journal.pntd.0001923.
65. Popugaeva E, Witkowski PT, Schlegel M, Ulrich RG, Auste B, Rang A, Kruger DH, Klempa B. 2012. Dobrava-Belgrade hantavirus from Germany shows receptor usage and innate immunity induction consistent with the pathogenicity of the virus in humans. PLoS One 7:e35587. doi:10 .1371/journal.pone.0035587.